Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › California
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in California
5 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in California.
Cities in California
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- City of Hope, Duarte
- Children's Hospital Los Angeles, Los Angeles
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
- Loma Linda University Children's Hospital, Loma Linda
- University of California, Los Angeles
- University of California, San Francisco
RecruitingPhase 1
Up to age 39 · All sexes · Updated Sep 11, 2026 · NCT04972942Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- Rady Children's Hospital, San Diego
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Aug 10, 2026 · NCT06390319A Registry for People With T-cell Lymphoma
- City of Hope Cancer Center (Data collection only), Duarte
- UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only), San Diego
- University of California San Francisco (Data collection only), San Francisco
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- City of Hope, Duarte
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 15, 2025 · NCT06462365From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.